Zagzag D, Miller D C, Knopp E, Farmer J P, Lee M, Biria S, Pellicer A, Epstein F J, Allen J C
Department of Pathology, New York University Medical Center, New York, New York, USA.
Pediatrics. 2000 Nov;106(5):1045-53. doi: 10.1542/peds.106.5.1045.
We discuss the clinical aspects, pathology, and molecular genetics of 7 patients with primitive neuroectodermal tumors (PNETs) arising in the brainstem that were treated at our institution from 1986 through 1995. Most neuro-oncologists avoid performing biopsies in children with pontine tumors. This article raises the question as to whether biopsies should be performed, because treatment recommendations might differ if a PNET was diagnosed rather than a pontine glioma.
We reviewed the clinical neuro-oncology database and the files of the Division of Neuropathology at New York University Medical Center from 1986 through 1995 and identified 7 histologically confirmed PNETs arising in the brainstem among 146 pediatric brainstem tumors. The clinical, neuroradiological, and neuropathological data were reviewed. Postmortem examinations were performed in 2 cases. Formalin-fixed, paraffin-embedded tumor tissues were also available in 6 of 7 patients that were tested for p53 gene mutations using single-strand conformation polymorphism analysis. We also tested 9 cerebellar PNETs, 9 brainstem gliomas, and 3 normal brains for p53 gene mutations as controls.
All 7 patients presented with focal cranial nerve deficits, and 2 were also hemiparetic. The median age at diagnosis was 2.7 (1-8 years). Magnetic resonance imaging (MRI) characteristics included a focal intrinsic exophytic nonenhancing brainstem lesion that had low T1-weighted and high T2-weighted signals. Hydrocephalus was present in 5 patients at diagnosis, 3 of whom had leptomeningeal dissemination. Meningeal dissemination occurred later in the course of the disease in 3 other patients. Five children required shunts at diagnosis and another 2 at recurrence. Despite therapy, all 7 PNET patients died within 17 months of diagnosis with a mean survival of 8 (4-17) months. No mutation in the p53 gene was detected.
Brainstem PNETs tend to arise at a younger age than brainstem gliomas and medulloblastomas. The MRI pattern suggests a localized rather than a diffuse intrinsic nonenhancing brainstem tumor. Like other PNETs, brainstem PNETs have a high predilection to disseminate within the central nervous system. The absence of p53 mutations is similar to other PNETs. Despite their origin close to the cerebellum, brainstem PNETs exhibit a more aggressive behavior and result in worse clinical outcomes than do cerebellar PNETs.
我们讨论了1986年至1995年在我院接受治疗的7例脑干原发性神经外胚层肿瘤(PNETs)患者的临床情况、病理及分子遗传学特征。大多数神经肿瘤学家避免对患有桥脑肿瘤的儿童进行活检。本文提出了是否应进行活检的问题,因为如果诊断为PNET而非桥脑胶质瘤,治疗建议可能会有所不同。
我们回顾了纽约大学医学中心临床神经肿瘤学数据库及神经病理学部门1986年至1995年的档案,在146例儿童脑干肿瘤中确定了7例经组织学证实的脑干PNETs。对临床、神经放射学及神经病理学数据进行了回顾。2例患者进行了尸检。7例患者中有6例可获得福尔马林固定、石蜡包埋的肿瘤组织,采用单链构象多态性分析检测p53基因突变。我们还检测了9例小脑PNETs、9例脑干胶质瘤及3例正常脑组织作为对照。
所有7例患者均出现局灶性颅神经功能缺损,2例还伴有偏瘫。诊断时的中位年龄为2.7岁(1 - 8岁)。磁共振成像(MRI)特征包括局灶性、内生性、外生性、无强化的脑干病变,T1加权像呈低信号,T2加权像呈高信号。5例患者诊断时存在脑积水,其中3例有软脑膜播散。另外3例患者在病程后期出现脑膜播散。5例儿童诊断时需要行分流术,另外2例复发时需要。尽管进行了治疗,所有7例PNET患者在诊断后17个月内死亡,平均生存期为8个月(4 - 17个月)。未检测到p53基因突变。
脑干PNETs的发病年龄往往比脑干胶质瘤和髓母细胞瘤更小。MRI表现提示为局限性而非弥漫性、内生性、无强化的脑干肿瘤。与其他PNETs一样,脑干PNETs极易在中枢神经系统内播散。p53基因未发生突变与其他PNETs相似。尽管起源于小脑附近,但脑干PNETs比小脑PNETs表现出更具侵袭性的行为,临床结局更差。